Abbott Laboratories's Revenue by Region
In fiscal year 2024, Abbott Laboratories's revenue by geographical region are as follows:
- CHINA: $2.11 B
- GERMANY: $2.54 B
- INDIA: $1.82 B
- JAPAN: $1.44 B
- NETHERLANDS: $1.12 B
- Non-US: $14.85 B
- SWITZERLAND: $1.75 B
- UNITED STATES: $16.32 B
Learn more about Abbott Laboratories’s Revenue by Products
Check out competitors to Abbott Laboratories in a side-by-side comparison.
Explore additional financial metrics for Abbott Laboratories.
| CANADA | 1280000000 |
|---|---|
| CHINA | 2133000000 |
| GERMANY | 2340000000 |
| INDIA | 1649000000 |
| JAPAN | 1932000000 |
| Non-US | 14841000000 |
| SWITZERLAND | 1336000000 |
| UNITED STATES | 18142000000 |
| CHINA | 2253000000 |
|---|---|
| GERMANY | 2345000000 |
| INDIA | 1750000000 |
| JAPAN | 1513000000 |
| NETHERLANDS | 1074000000 |
| Non-US | 14084000000 |
| SWITZERLAND | 1638000000 |
| UNITED STATES | 15452000000 |
| CHINA | 2113000000 |
|---|---|
| GERMANY | 2539000000 |
| INDIA | 1817000000 |
| JAPAN | 1441000000 |
| NETHERLANDS | 1124000000 |
| Non-US | 14846000000 |
| SWITZERLAND | 1747000000 |
| UNITED STATES | 16323000000 |
The above chart shows Abbott Laboratories's revenue percentage share by geographical region.
In fiscal year 2022, Abbott Laboratories's revenue by region is as follows:
- CANADA generated $1.28 B in revenue, representing 2.93% of its total revenue.
- CHINA generated $2.13 B in revenue, representing 4.89% of its total revenue.
- GERMANY generated $2.34 B in revenue, representing 5.36% of its total revenue.
- INDIA generated $1.65 B in revenue, representing 3.78% of its total revenue.
- JAPAN generated $1.93 B in revenue, representing 4.43% of its total revenue.
- Non-US generated $14.84 B in revenue, representing 34% of its total revenue.
- SWITZERLAND generated $1.34 B in revenue, representing 3.06% of its total revenue.
- UNITED STATES generated $18.14 B in revenue, representing 41.56% of its total revenue.
The biggest region for Abbott Laboratories is the UNITED STATES, which represents 41.56% of its total revenue.
The smallest region for Abbott Laboratories is the CANADA, which represents 2.93% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by geographical region.
In fiscal year 2023, Abbott Laboratories's revenue by region is as follows:
- CHINA generated $2.25 B in revenue, representing 5.62% of its total revenue.
- GERMANY generated $2.35 B in revenue, representing 5.85% of its total revenue.
- INDIA generated $1.75 B in revenue, representing 4.36% of its total revenue.
- JAPAN generated $1.51 B in revenue, representing 3.77% of its total revenue.
- NETHERLANDS generated $1.07 B in revenue, representing 2.68% of its total revenue.
- Non-US generated $14.08 B in revenue, representing 35.11% of its total revenue.
- SWITZERLAND generated $1.64 B in revenue, representing 4.08% of its total revenue.
- UNITED STATES generated $15.45 B in revenue, representing 38.53% of its total revenue.
The biggest region for Abbott Laboratories is the UNITED STATES, which represents 38.53% of its total revenue.
The smallest region for Abbott Laboratories is the NETHERLANDS, which represents 2.68% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by geographical region.
In fiscal year 2024, Abbott Laboratories's revenue by region is as follows:
- CHINA generated $2.11 B in revenue, representing 5.04% of its total revenue.
- GERMANY generated $2.54 B in revenue, representing 6.05% of its total revenue.
- INDIA generated $1.82 B in revenue, representing 4.33% of its total revenue.
- JAPAN generated $1.44 B in revenue, representing 3.44% of its total revenue.
- NETHERLANDS generated $1.12 B in revenue, representing 2.68% of its total revenue.
- Non-US generated $14.85 B in revenue, representing 35.39% of its total revenue.
- SWITZERLAND generated $1.75 B in revenue, representing 4.16% of its total revenue.
- UNITED STATES generated $16.32 B in revenue, representing 38.91% of its total revenue.
The biggest region for Abbott Laboratories is the UNITED STATES, which represents 38.91% of its total revenue.
The smallest region for Abbott Laboratories is the NETHERLANDS, which represents 2.68% of its total revenue.
Summary Table
| Geography (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| CANADA | 2.93% | 0% | 0% |
| CHINA | 4.89% | 5.62% | 5.04% |
| GERMANY | 5.36% | 5.85% | 6.05% |
| INDIA | 3.78% | 4.36% | 4.33% |
| JAPAN | 4.43% | 3.77% | 3.44% |
| NETHERLANDS | 0% | 2.68% | 2.68% |
| Non-US | 34% | 35.11% | 35.39% |
| SWITZERLAND | 3.06% | 4.08% | 4.16% |
| UNITED STATES | 41.56% | 38.53% | 38.91% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Abbott Laboratories.
In fiscal year 2024, the UNITED STATES generated the most revenue ($16.32 B), and the NETHERLANDS generated the least revenue ($1.12 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Region | 2022 | 2023 | 2024 |
|---|---|---|---|
| CANADA | $1.28 B - | - - | - - |
| CHINA | $2.13 B - |
$2.25 B
5.63%
|
$2.11 B
6.21%
|
| GERMANY | $2.34 B - |
$2.35 B
0.21%
|
$2.54 B
8.27%
|
| INDIA | $1.65 B - |
$1.75 B
6.12%
|
$1.82 B
3.83%
|
| JAPAN | $1.93 B - |
$1.51 B
21.69%
|
$1.44 B
4.76%
|
| NETHERLANDS | - - | $1.07 B - |
$1.12 B
4.66%
|
| Non-US | $14.84 B - |
$14.08 B
5.10%
|
$14.85 B
5.41%
|
| SWITZERLAND | $1.34 B - |
$1.64 B
22.60%
|
$1.75 B
6.65%
|
| UNITED STATES | $18.14 B - |
$15.45 B
14.83%
|
$16.32 B
5.64%
|
| Total Revenue | $43.65 B - |
$40.11 B
8.12%
|
$41.95 B
4.59%
|
Related
-
Agilent Technologies Revenue by Region
-
Eli Lilly and Company Revenue by Region
-
Stryker Corporation Revenue by Region
-
Johnson & Johnson Revenue by Region
-
AbbVie Revenue by Region
-
Merck & Co. Revenue by Region
-
Thermo Fisher Scientific Revenue by Region
-
Danaher Corporation Revenue by Region
-
Amgen Revenue by Region
-
Pfizer Revenue by Region
